These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9451719)

  • 1. Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.
    Schmidt DE; Ebert MH; Lynn JC; Whetsell WO
    J Neural Transm (Vienna); 1997; 104(8-9):875-85. PubMed ID: 9451719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
    Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
    Wu RM; Mohanakumar KP; Murphy DL; Chiueh CC
    Ann N Y Acad Sci; 1994 Nov; 738():214-21. PubMed ID: 7832430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal protective and rescue effects of deprenyl against MPP+ dopaminergic toxicity.
    Wu RM; Murphy DL; Chiueh CC
    J Neural Transm Gen Sect; 1995; 100(1):53-61. PubMed ID: 8748663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical evaluation of the neurotoxicity of MPTP and MPP⁺ in embryonic and newborn mice.
    Sai T; Uchida K; Nakayama H
    J Toxicol Sci; 2013; 38(3):445-58. PubMed ID: 23665943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
    Thiffault C; Lamarre-Théroux L; Quirion R; Poirier J
    Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens.
    Wu WR; Zhu ZT; Zhu XZ
    Life Sci; 2000 Jun; 67(3):241-50. PubMed ID: 10983868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition.
    Le W; Jankovic J; Xie W; Kong R; Appel SH
    Neurosci Lett; 1997 Mar; 224(3):197-200. PubMed ID: 9131670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo.
    Wu RM; Chiueh CC; Pert A; Murphy DL
    Eur J Pharmacol; 1993 Oct; 243(3):241-7. PubMed ID: 8276076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
    Wu RM; Chen RC; Chiueh CC
    Ann N Y Acad Sci; 2000; 899():255-61. PubMed ID: 10863544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS; Schneider JS
    Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Mytilineou C; Cohen G
    J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine and cyclocreatine attenuate MPTP neurotoxicity.
    Matthews RT; Ferrante RJ; Klivenyi P; Yang L; Klein AM; Mueller G; Kaddurah-Daouk R; Beal MF
    Exp Neurol; 1999 May; 157(1):142-9. PubMed ID: 10222117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium.
    Koutsilieri E; Chen TS; Rausch WD; Riederer P
    Eur J Pharmacol; 1996 Jun; 306(1-3):181-6. PubMed ID: 8813631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MPTP- and MPP(+)-induced effects on body temperature exhibit age- and strain-dependence in mice.
    Freyaldenhoven TE; Ali SF; Hart RW
    Brain Res; 1995 Aug; 688(1-2):161-70. PubMed ID: 8542303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
    Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU
    Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Castagnoli K; Palmer S; Castagnoli N
    Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.